Orchestra BioMed Holdings, Inc. Profile Avatar - Palmy Investing

Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (S…

Biotechnology
US, New Hope [HQ]

Cash Flow Statements

Loading...
End of OBIO's Analysis
CIK: - CUSIP: 68572M106 ISIN: US68572M1062 LEI: - UEI: -
Secondary Listings
OBIO has no secondary listings inside our databases.